Drug intelligence / Profile preview

guaifenesin + pseudoephedrine + hydrocodone

Development stage
Unknown
Lead developer
China National Accord Medicines
Modality
Small Molecules
Administration
Oral
01

Overview

guaifenesin + pseudoephedrine + hydrocodone is a fixed-dose combination pharmaceutical product used for the symptomatic relief of cough, nasal congestion, and chest congestion associated with the common cold or influenza. It combines three active ingredients with distinct mechanisms: **guaifenesin**, an expectorant that increases the volume and reduces the viscosity of respiratory tract secretions; **pseudoephedrine**, a sympathomimetic decongestant that stimulates alpha-adrenergic receptors to produce vasoconstriction in the nasal mucosa; and **hydrocodone**, an opioid antitussive that suppresses the cough reflex by acting directly on the cough center in the medulla. Developed by entities such as Shenzhen Pharmaceutical Factory, this combination is typically administered as an oral solution and is indicated for adult patients requiring multi-symptom relief from upper respiratory tract infections.

Brand names
Hycofenix
Other names
hydrocodone bitartrate, pseudoephedrine hydrochloride, and guaifenesin oral solution
02

Targets

ADRA2A (α2A)DOR (Opioid Receptor Delta 1)KOR (Kappa opioid receptor)MOR (Mu opioid receptor)SIGMAR1 (Sigma non-opioid intracellular receptor 1)ADRA1A (α1A)

Beyond the preview

Go deeper on guaifenesin + pseudoephedrine + hydrocodone.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on guaifenesin + pseudoephedrine + hydrocodone.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call